TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 44 filers reported holding TARSUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,683,442 | +27.4% | 544,932 | +29.5% | 0.00% | – |
| Q2 2023 | $7,602,338 | +66.0% | 420,716 | +15.5% | 0.00% | – |
| Q1 2023 | $4,579,188 | -54.9% | 364,295 | -47.5% | 0.00% | – |
| Q4 2022 | $10,164,072 | +102.6% | 693,320 | +136.5% | 0.00% | – |
| Q3 2022 | $5,018,000 | +45.3% | 293,111 | +23.9% | 0.00% | – |
| Q2 2022 | $3,453,000 | +54.5% | 236,516 | +78.0% | 0.00% | – |
| Q1 2022 | $2,235,000 | -23.4% | 132,883 | +2.4% | 0.00% | – |
| Q4 2021 | $2,919,000 | +6.8% | 129,742 | +2.3% | 0.00% | – |
| Q3 2021 | $2,733,000 | -20.9% | 126,802 | +6.4% | 0.00% | – |
| Q2 2021 | $3,453,000 | +6.7% | 119,141 | +18.7% | 0.00% | – |
| Q1 2021 | $3,235,000 | -19.2% | 100,384 | +3.6% | 0.00% | – |
| Q4 2020 | $4,004,000 | – | 96,884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |